CIK 0001710340 · Non-accelerated filer<br>Smaller reporting company
Eton Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ETON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 371858472
- Phone
- (847) 787-7361
- Business address
- 21925 W. FIELD PARKWAY, SUITE 235, DEER PARK, IL, 60010-7278
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Acquisition or sale completed
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change
- 8-K Event Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4/A Open-market sale 10% owner sold 28,315 shares at $37.54 ($1,063,033)
- 4 Open-market sale 10% owner sold 28,315 shares at $37.54 ($1,063,033)
- 4 Option exercise President & CEO acquired 227,500 shares (option exercise)
- 4 Option exercise Chief Business Officer acquired 10,000 shares (option exercise)
- 4 Open-market sale 10% owner sold 126,685 shares at an average $37.64 ($4,768,637)
Page 2 of 22 · 425 filings